Greater London, England, United Kingdom
Contact Info
2K followers
500+ connections
About
- R&D transformation
- R&D value measurement and return on…
Activity
-
Very pleased to share that my article co-written with Keiko Behrens has been published on Balkan Diskurs!
Very pleased to share that my article co-written with Keiko Behrens has been published on Balkan Diskurs!
Liked by Julian Remnant
-
What's worth celebrating?! Promotions for some of our most fabulous leaders in Deloitte #LifeSciencesAndHealthCare. What a bunch of legends!…
What's worth celebrating?! Promotions for some of our most fabulous leaders in Deloitte #LifeSciencesAndHealthCare. What a bunch of legends!…
Liked by Julian Remnant
-
One of the biggest challenges in AI image generation has been keeping the same characters in each image. There has been a fantastic paper from…
One of the biggest challenges in AI image generation has been keeping the same characters in each image. There has been a fantastic paper from…
Liked by Julian Remnant
Licenses & Certifications
Publications
-
Developing a True Strategic Partnership
PharmaVOICE
See publicationIndustry leaders have spoken for years about the need to move beyond transactional outsourcing to more strategic partnerships. The time may finally be right for the strategic outsourcing model to take hold. Julian is an expert contributor to the article.
-
Impact of Healthcare Reforms on R&D
Pharma Times
This leader explores how R&D will need to adapt to respond to the impact of healthcare reforms.
Other authors -
-
Output-Based Measures Needed for Pharma R&D Investment
Pharma Times
This joint research into the value generated by life sciences R&D highlights the need for output-based value metrics. We have developed peer benchmarks for the top 12 pharma companies with respect to the return on investment expected from each of their late stage pipelines. As growth becomes more elusive in life sciences, capital allocation is scrutinised more than ever, and R&D needs to demonstrate it is earning its investment.
Other authors -
-
Pharmaceutical R&D is Healthy But Needs to be Fitter
Deloitte
See publicationProprietary research study into the value generated from R&D by the top 12 pharma companies, and the results of our value simulations that reveal the levers that most influence value realisation in R&D.
-
Drug Groups’ Investments Pay Off
Financial Times
This joint research into the value generated by life sciences R&D highlights the need for output-based value metrics. We have developed peer benchmarks for the top 12 pharma companies with respect to the return on investment expected from each of their late stage pipelines. As growth becomes more elusive in life sciences, capital allocation is scrutinised more than ever, and R&D needs to demonstrate it is earning its investment.
Other authors -
Languages
-
English
Native or bilingual proficiency
-
French
Limited working proficiency
-
German
Elementary proficiency
More activity by Julian
-
24 peaks in 24 hours nailed! We did it for Motivation - Making Space for Disability. Thank you for your kind donations
24 peaks in 24 hours nailed! We did it for Motivation - Making Space for Disability. Thank you for your kind donations
Liked by Julian Remnant
-
Well said. Very proud to have been part of this incredible achievement. The result of amazing people at #AZ #ServiceNow and #Deloitte working…
Well said. Very proud to have been part of this incredible achievement. The result of amazing people at #AZ #ServiceNow and #Deloitte working…
Liked by Julian Remnant
-
Incredible honor! 👏👏! Proud to be partnering with our Life Sciences clients on their transformational change efforts. 🥇
Incredible honor! 👏👏! Proud to be partnering with our Life Sciences clients on their transformational change efforts. 🥇
Liked by Julian Remnant
-
Wow. No other words for it. What a privilege to support our next generation of leaders on the first Empower programme taking place in our new…
Wow. No other words for it. What a privilege to support our next generation of leaders on the first Empower programme taking place in our new…
Liked by Julian Remnant
-
What if AI could seamlessly take over your video conversations when you need to step away? I've built a proof-of-concept that does just that: -…
What if AI could seamlessly take over your video conversations when you need to step away? I've built a proof-of-concept that does just that: -…
Liked by Julian Remnant
-
🎤 Marcus Williamson, Managing Partner at Deloitte Technology Delivery Center had an insightful opening speech at Java Stars Summit during Bucharest…
🎤 Marcus Williamson, Managing Partner at Deloitte Technology Delivery Center had an insightful opening speech at Java Stars Summit during Bucharest…
Liked by Julian Remnant
-
So excited to finally facilitate at our new Deloitte University facility in Paris! This venue is amazing. Looking forward to working with my group of…
So excited to finally facilitate at our new Deloitte University facility in Paris! This venue is amazing. Looking forward to working with my group of…
Liked by Julian Remnant
-
Excited to share that I have taken on a new role as Managing Director, CFO & Enterprise Value, in Accenture’s Strategy & Consulting Team. Thank you…
Excited to share that I have taken on a new role as Managing Director, CFO & Enterprise Value, in Accenture’s Strategy & Consulting Team. Thank you…
Liked by Julian Remnant
-
Pleased that the completion of the up to $1.05 billion acquisition of Amolyt Pharma by AstraZeneca has been announced today. Novo Holdings Venture…
Pleased that the completion of the up to $1.05 billion acquisition of Amolyt Pharma by AstraZeneca has been announced today. Novo Holdings Venture…
Liked by Julian Remnant
-
My guest on this week's episode of Leading 4 Life "Stories" is Air Chief Marshal Sir Stephen Hillier, currently the Chair of the UK Civil Aviation…
My guest on this week's episode of Leading 4 Life "Stories" is Air Chief Marshal Sir Stephen Hillier, currently the Chair of the UK Civil Aviation…
Liked by Julian Remnant
-
On Tuesday morning I had the special privilege of hosting the inaugural event at our Deloitte Life Sciences Catalyst Business Lounge. Thank you to…
On Tuesday morning I had the special privilege of hosting the inaugural event at our Deloitte Life Sciences Catalyst Business Lounge. Thank you to…
Liked by Julian Remnant
-
📢 We’re beyond thrilled to announce the addition of four dynamic new directors to our leadership team at #DeloitteCyprus! 🎉 Join us in celebrating:…
📢 We’re beyond thrilled to announce the addition of four dynamic new directors to our leadership team at #DeloitteCyprus! 🎉 Join us in celebrating:…
Liked by Julian Remnant
-
Yesterday, we completed our third delivery of ‘Leadership in the Boardroom’ – our two-day Deloitte partner training programme - at our fantastic new…
Yesterday, we completed our third delivery of ‘Leadership in the Boardroom’ – our two-day Deloitte partner training programme - at our fantastic new…
Liked by Julian Remnant
-
I’m delighted to announce that I have today joined Mishcon de Reya as a partner in the Innovation team. In my new role I’ll continue to assist…
I’m delighted to announce that I have today joined Mishcon de Reya as a partner in the Innovation team. In my new role I’ll continue to assist…
Liked by Julian Remnant
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More